Forward Citations = 2

Loading Chart...

2 inventors (with patents filed for the assignee):

Shaker Ahmed Mousa (4 out of 81 patents)

Robert J Linhardt (2 out of 41 patents)

4 patents: Sort by Forward Citations

1. 9580395 - Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders (2017-02-28),

2. 8859539 - Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders (2014-10-14),

3. 8607989 - Filter composites for drug detoxification (2013-12-17),

4. 8314078 - Silver nanoparticles as anti-microbial (2012-11-20),

Vascular Vision Pharmaceutical Company is a leading biopharmaceutical firm focused on developing innovative treatments for cardiovascular diseases. We specialize in creating advanced therapies that target vascular conditions to improve patient outcomes. With a commitment to cutting-edge research and clinical excellence, Vascular Vision Pharma is dedicated to revolutionizing the field of cardiovascular medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#5 in Rensselaer, NY

#3,528 in New York

#59,047 in US

Rensselaer, NY, United States of America

Vascular Vision Pharmaceutical Company

Forward Citations = 2

2 inventors:

Shaker Ahmed Mousa (4 out of 81 patents)

Robert J Linhardt (2 out of 41 patents)

Please report any incorrect information to support@idiyas.com